Pulmonx Stock

pulmonx.comHealthcare / Other HealthcareFunding to Date: $226.39MM

Pulmonx is the developer of the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema.

Register To Buy and Sell Shares

For more details on financing and valuation for Pulmonx, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Pulmonx’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Pulmonx.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Martin Schneider
Chief Financial Officer, Pulmonx International SARL & Vice President, Finance & Administration
Glendon French
Chief Executive Officer, President & Board Member
Rodney Perkins MD
Founder & Chairman of the Board

Board Members

Charles Chon
Oern Stuge MD
Rodney Perkins MD
Stephen Salmon
Dana Mead Jr.
Kleiner Perkins
Richard Ferrari
De Novo Ventures
Staffan Lindstrand
Glendon French
Michael Matly MD
Montreux Growth Partners
Annette Campbell-White
MedVenture Associates

News Highlights

Pulmonx Closes $65 Million Financing and Adds Chief Financial Officer
Pulmonx Corporation, a global leader in diagnostic and therapeutic pulmonary device technologies, announced today the closing of an oversubscribed $65
Updated on: Dec 2, 2023


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.